Monday, December 30, 2024

Canada’s Politics and Government News Source Since 1989

Monday, December 30, 2024 | Latest Paper

In strengthening Canada’s health care, we must maintain employer-sponsored drug plans

Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to new drugs, and higher costs for employers, unions, and families.

Opinion
BY CAROLYNE EAGAN
February 21, 2024

Opinion | BY CAROLYNE EAGAN | February 21, 2024

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Bridging the gap between science and policy for precision medicine

OpinionBY PIERRE D. SARR

Islam’s true voice: wresting the microphone from extremists

OpinionBY IMAM MOHAMMAD TAWHIDI, IMAM INAYAT ALI SHAKIR, IMAM PAUL SALAHUDDIN ARMSTRONG, IMAM MOHAMMAD MEHDIZADE

Bill C-282 in the best interest of Canadian agriculture: Peterborough mayor

OpinionBY JEFF LEAL

Investing in youth is essential for Canada’s future

OpinionBY KAREN MYERS

Canada’s health system has an accountability problem

OpinionBY JOSS REIMER

Related Stories

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

Time for Canada to step up on drug coverage, says Toronto doctor

Single-payer pharmacare plan remains the best option, says Toronto reader

Universal pharmacare plan needs to improve access without disrupting care

OpinionBY SANDRA HANNA

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.

Time for Canada to step up on drug coverage, says Toronto doctor

Time for Canada to step up on drug coverage, says Toronto doctor

Single-payer pharmacare plan remains the best option, says Toronto reader

Single-payer pharmacare plan remains the best option, says Toronto reader

Universal pharmacare plan needs to improve access without disrupting care

OpinionBY SANDRA HANNA

Policymakers need to ensure there are no disruptions or diminished access to medications for Canadians who already have some form of drug coverage through their own benefits programs.

Universal pharmacare plan needs to improve access without disrupting care

OpinionBY SANDRA HANNA

Policymakers need to ensure there are no disruptions or diminished access to medications for Canadians who already have some form of drug coverage through their own benefits programs.